知网在线教学  
录播课程 中医药防治新冠肺炎/Prevention and Treatment of COVID-19 with TCM
综合评分5.0 浏览2038 收藏8
课程概述 课程目录 相关资料 课后作业 学习讨论 课程评价(0)

1. 演讲题目/Topic:
(1) 新发传染病中医预防、治疗与康复的思考——以新冠病毒病为例
     Prevention, Treatment and Rehabilitation of Emerging Infectious Diseases: Taking COVID-19 for Instance
(2) 后疫情时期新冠肺炎的防控关键人群、卫生策略与科研方向
     Key Populations, Health Strategies and Research Directions for Prevention and Control of COVID-19 in Post-epidemic Period in China
(3) 中医药防治新冠肺炎循证证据与当前全球热点
     Evidence of TCM in COVID-19 Prevention & Treatment and Current Global Hotspots

    公益播放期间,本课程浏览和学习达到409人次。
    During public welfare period, this lecture has attracted 409 visitors and learners.

2. 演讲语言/Language:
        英文语音&中文字幕/English voice & Chinese subtitles

3. 演讲嘉宾/Lecturers:
       (1) 杜宏波,博士,主任医师,北京中医药大学东直门医院脾胃病科/感染科主任,原国家卫生应急队队员,从事病毒性肝病及新发突发传染病的中西医结合研究,参与过手足口病、甲型H1N1流感及新冠肺炎的一线防控。发表新冠论文3篇。
       DU Hongbo, doctor of medicine, chief physician, director of the Department of Spleen and Stomach Diseases/Infectious Diseases, Dongzhimen Hospital, Beijing University of Chinese Medicine, and former member of the National Health Emergency Response Team, specializes in treating viral liver diseases and emerging and acute infectious diseases with integrated traditional Chinese and Western medicine. He has been involved in the first-line prevention and control of hand-foot-and-mouth disease, H1N1 influenza and COVID-19 and published 3 papers concerning COVID-19.

       (2) 李小科,副主任医师,长期从事病毒感染性疾病的临床科研。现任北京中医药大学肝病研究所科研秘书。
       LI Xiaoke, deputy chief physician, has long been involved in the clinical research on viral infectious diseases. He is currently the scientific secretary of the Institute of Liver Diseases at Beijing University of Chinese Medicine.

       (3) 陈光,医学博士,哈佛大学医学院医学科学硕士在读,从事临床研究与转化医学研究。目前参与世界卫生组织关于COVID-19社交距离及辅助通气的系统评价,COVID-19相关论文共2篇,分别发表在《柳叶刀》及《美国内科学年鉴》杂志。
       CHEN Guang, Doctor of medicine and MMS candidate of Harvard Medical School, has engaged himself in clinical and translational medical research. Currently, he is involved in the systematic review of social distancing and assisted ventilation in COVID-19 patients organized by the WHO, with two papers published on The Lancet and Annals of Internal Medicine.

4. 演讲内容/Abstract:
       (1) 新冠病毒病已经成为全球大流行疾病,目前尚无特效疗法。中医药在新发传染病防控领域具有较多实践经验,但需要进行更加严谨的总结、研究和提升。中医药在新冠病毒病的防治中发挥了较为积极的作用,结合新冠肺炎的防控实践和个人思考,对新发传染病的中医药预防、治疗及康复进行讨论。
        COVID-19 has quickly evolved into a global pandemic, but no specific treatment is available currently. Traditional Chinese medicine (TCM) has accumulated rich experience in preventing and treating emerging infectious diseases, while deserves to be precisely summarized, studied and improved. TCM has played a positive role in the control of COVID-19 in China. Based on the prevention and control practices against COVID-19, he would like to share some ideas on TCM prevention, treatment and rehabilitation of emerging infectious diseases.

       (2) 目前COVID-19在中国已经得到了较有效的控制,其他国家地区采取与中国不同的防疫措施,客观来讲,任何措施都需要权衡利弊。相比于其他国家,我国已经提前进入了后疫情时期。疫情的影响是长期的,如何聚焦防控疫情的关键人群,并借鉴其他国家的经验,制定合理的公共卫生策略?
       COVID-19 has been brought under control in China. Some other countries have adopted preventative measures different from those in China, and the pros and cons of all these measures need to be weighed objectively. China has entered the post-epidemic period earlier than other countries. The impact of the epidemic is expected to be long-lasting. How to focus on the key populations in preventing and controlling the epidemic? How to learn from the experience of other countries to develop a reasonable public health strategy in the coming future?

       (3) 新冠肺炎是传染性疾病,当前疾病负担仍较严重,构成全球公共卫生问题。在中国,中医药的方法应用于新冠肺炎的预防、治疗、预后等方面。目前其证据如何?能否得到WHO的推荐及全球的认可及推广应用?目前什么是新冠肺炎临床及科研关注的热点?未来中医药防治的研究该何去何从?

       COVID-19 is an infectious disease that has exerted a heavy burden on society and posed a threat to global public health. TCM has been used in China to prevent and treat COVID-19 since its outbreak. Nevertheless, what is the magnitude of the association between TCM therapy and the outcome? Is it possible for WHO to recommend TCM in COVID-19 guideline, promoting its application worldwide? What is the prevailing issues regarding this disease, and where should TCM research step in and make strides in the near future?



推荐电子书/Recommended e-books:

     

双语版/Bilingual editionhttp://jtp.cnki.net/bilingual/EBook/Detail?pykm=TCMC

中文版/Chinese editionhttps://book.oversea.cnki.net/CCGBWEB/Book/Detail/OB200803001

英文版/English editionhttps://book.oversea.cnki.net/CCGBWEB/Book/Detail/OB200803002

电子书可在网站注册下单或联系销售人员订购/Place your order on website or contact with our sales managers

marketing@int.cnki.net

beijing@cnki.net


综合评分 5.0
我们是来自中国知网科技双语出版中心的团队,是目前中国知网第一支,也是唯一一支科技领域中英双语出版的团队。产品涉及基础科学、工程技术、农业科学、医药卫生、环境生态... 更多
相关课程 更多
  • 回放
    新型冠状病毒肺炎中医药防治实践—河南省临床救治示范
    CNKI科技双语出...
    2020/06/02 20:20
  • 回放
    重型及危重型新冠疾病的中医药救治体会
    CNKI科技双语出...
    2020/06/05 20:20
  • 回放
    中西医结合防治COVID-19 武汉雷神山医院方案及经验介绍
    CNKI科技双语出...
    2020/06/08 20:20
  • 回放
    Understanding of COVID-19 Infection Based on Traditional and Modern Medicine
    CNKI科技双语出...
    2020/06/10 20:20